Is Nabriva Therapeutics PLC - ADR (NBRV) Stock a Smart Investment Tuesday?

Tuesday, February 14, 2023 01:03 PM | InvestorsObserver Analysts

Mentioned in this article

Is Nabriva Therapeutics PLC - ADR (NBRV) Stock a Smart Investment Tuesday?

Nabriva Therapeutics PLC - ADR (NBRV) stock is down -86.13% over the last 12 months, and the average rating from Wall Street analysts is a Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 4 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 4. NBRV's rank also includes a long-term technical score of 7.

NBRV has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock has risen 1.18% while the S&P 500 is down -0.39% as of 12:55 PM on Tuesday, Feb 14. NBRV is higher by $0.02 from the previous closing price of $1.70 on volume of 4,902 shares. Over the past year the S&P 500 is down -6.37% while NBRV is down -86.13%. NBRV lost -$19.49 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.